From: A novel approach to investigate tissue-specific trinucleotide repeat instability
Name | Size | NES | P value |
---|---|---|---|
Negative correlation | Â | Â | Â |
G1 to S cell cycle reactome | 150 | -1.87 | 0.0000 |
Nuclear membrane | 208 | -1.72 | 0.0023 |
Negative regulation of progression through cell cycle | 183 | -1.64 | 0.0024 |
Mitosis | 261 | -1.82 | 0.0044 |
M phase of mitotic cell cycle | 262 | -1.81 | 0.0044 |
Protein kinase inhibitor activity | 41 | -1.71 | 0.0046 |
G1 pathway | 68 | -1.85 | 0.0046 |
Cell cycle pathway | 57 | -1.85 | 0.0066 |
Mitotic cell cycle | 427 | -1.76 | 0.0069 |
Kinase inhibitor activity | 42 | -1.72 | 0.0070 |
Protein amino acid-ribosylation | 30 | -1.92 | 0.0071 |
Eicosanoid synthesis | 29 | -1.79 | 0.0072 |
P53 pathway | 43 | -1.77 | 0.0085 |
Notch pathway | 17 | -1.70 | 0.0086 |
Cell cycle | 176 | -1.82 | 0.0087 |
Integrin mediated cell adhesion | 222 | -1.73 | 0.0089 |
RNA helicase activity | 41 | -1.78 | 0.0097 |
Positive correlation | Â | Â | Â |
UDP-galactose beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity | 21 | 1.84 | 0.0000 |
Adrenoceptor activity | 25 | 1.94 | 0.0017 |
Amine receptor activity | 47 | 1.88 | 0.0018 |
Beta-1,3-galactosyltransferase activity | 25 | 1.94 | 0.0020 |
Mono amine GPCRS | 45 | 1.88 | 0.0038 |
Glutamate metabolism | 51 | 1.78 | 0.0042 |
Neuromuscular junction development | 15 | 1.76 | 0.0057 |
Serotonin receptor activity | 22 | 1.81 | 0.0057 |
Oxidoreductase activity, acting on the CH-CH groups of donors, oxygen as acceptor | 15 | 1.72 | 0.0064 |